Invest in Compliance Automation

Solformis targets the $3.2 billion life sciences compliance market with a scalable AI-driven solution proven to cut cycle times and reduce risk.

Progress & Traction

  • Executing 60-day validation roadmap
  • Engaged with key mid-size pharma and device companies for pilot
  • Early advisor endorsements and prototype feedback

Team & Credentials

  • Founders with decades of combined experience
  • Advisors from FDA, top pharma, and AI research
  • Easy onboarding and off-ramp options

Your confidential feedback, received in under 5 minutes, will directly shape RuleSync's design.

All responses are confidential and used solely for research and product development purposes.

After you submit, we’ll share a summary of key insights and invite you to join our pilot program.